CIK 0001830214
- Accelerated filer
Ginkgo Bioworks Holdings, Inc.
Sign in to watch- Ticker
- DNA
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 872652913
- Phone
- +1 877-442-5362
- Business address
- 27 DRYDOCK AVENUE, 8TH FLOOR, BOSTON, MA, 02210
- Former names
- Soaring Eagle Acquisition Corp., Spinning Eagle Acquisition Corp.
- 4 Planned sale Director sold 4,500 shares at $1.39 ($6,255)
- 4 Open-market sale See remarks sold 37,229 shares at $1.50 ($55,918)
- 4 Planned sale See remarks sold 75,300 shares at an average $1.43 ($107,641)
- 4 Planned sale 10% owner sold 75,300 shares at an average $1.43 ($107,641)
- 4 Planned sale See remarks sold 200,000 shares at an average $1.43 ($285,800)
- 4 Planned sale See remarks sold 75,300 shares at an average $1.47 ($110,540)
- 4 Planned sale See remarks sold 200,000 shares at an average $1.47 ($293,500)
- 4 Planned sale 10% owner sold 75,300 shares at an average $1.47 ($110,540)
- 4 Planned sale 10% owner sold 75,300 shares at an average $1.65 ($124,132)
- 4 Planned sale See remarks sold 200,000 shares at an average $1.65 ($329,600)
- 4 Planned sale See remarks sold 75,300 shares at an average $1.65 ($124,132)
- 4 Planned sale See remarks sold 200,000 shares at an average $1.71 ($341,200)
- 4 Planned sale 10% owner sold 75,300 shares at an average $1.71 ($128,499)
- 4 Planned sale See remarks sold 75,300 shares at an average $1.71 ($128,499)
- 4 Planned sale See remarks sold 75,300 shares at an average $1.64 ($123,643)
- 4 Planned sale See remarks sold 200,000 shares at an average $1.64 ($328,200)
- 4 Planned sale 10% owner sold 75,300 shares at an average $1.64 ($123,643)
- 4/A Planned sale Director sold 4,499 shares at $1.78 ($8,008)
- 4 Planned sale Director sold 4,499 shares at $4,499.00 ($20,241,001)
- 4 Open-market sale See remarks sold 42,237 shares at $1.76 ($74,464)
Page 7 of 24 · 474 filings